e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical presentation and outcomes of venous thrombo-embolic diseases in chronic obstructive pulmonary diseases. Findings from the RIETE Registry
L. Bertoletti, S. Quenet, K. Rivron-Guillot, A. Perrier, L. Hernández, J. J. Martín-Villasclaras, M. Monreal, RIETE Investigators (Saint-Etienne, France; , Switzerland; Málaga, Barcelona, Spain)
Source:
Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Session:
Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Session type:
Thematic Poster Session
Number:
4524
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Bertoletti, S. Quenet, K. Rivron-Guillot, A. Perrier, L. Hernández, J. J. Martín-Villasclaras, M. Monreal, RIETE Investigators (Saint-Etienne, France; , Switzerland; Málaga, Barcelona, Spain). Clinical presentation and outcomes of venous thrombo-embolic diseases in chronic obstructive pulmonary diseases. Findings from the RIETE Registry. Eur Respir J 2010; 36: Suppl. 54, 4524
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Related content which might interest you:
Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry
Source: Eur Respir J, 52 (6) 1801687; 10.1183/13993003.01687-2018
Year: 2018
Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry
Source: ERJ Open Res, 7 (3) 00850-2020; 10.1183/23120541.00850-2020
Year: 2021
Chronic obstructive pulmonary disease and venous thromboembolism recurrents : A prospective study
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Venous thromboembolic (VTE) disease in people with chronic obstructive pulmonary disease (COPD): A matched case-control study
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015
Cardiovascular comorbidities in chronic obstructive pulmonary disease patients
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a psychiatric disorder
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Management of chronic thromboembolic pulmonary hypertension (CTEPH): A physician-based perception study
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012
Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Epidemiology and costs of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 27: 188-207
Year: 2006
Epidemiology and costs of chronic obstructive pulmonary disease - Supplementary material: Final Q and A Global Burden of COPD
Source: Eur Respir J 2006; 27: 188-207
Year: 2006
Characteristics of chronic thromboembolic pulmonary hypertension in Ireland
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021
Chronic thromboembolic pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 108-118
Year: 2012
Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases
Source: Eur Respir Monogr 2020; 88: 167-183
Year: 2020
Association of clinical characteristics with HLA in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003
Comorbidities in chronic obstructive pulmonary disease: a nation-wide twin study
Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Year: 2018
Comorbidities in chronic obstructive pulmonary disease - Results of a national multicenter research project
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Cardiovascular risk factors in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept